Neurocrine Biosciences (NBIX) Revenue (2010 - 2026)
Neurocrine Biosciences (NBIX) reported Revenue of $959 million for Q2 2026, up 39.5% from $687.5 million a year earlier and up 17.7% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Revenue (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Neurocrine Biosciences' Revenue came in at $3.37 billion, up 34.4% year-over-year; for FY2025, it came in at $2.86 billion, up 21.4% from FY2024.
- Revenue has increased for nine consecutive years, with a five-year compound annual growth rate of 22.3% (FY2020 to FY2025).
- By year, Revenue came in at $2.36 billion in FY2024 (+24.8%), $1.89 billion in FY2023 (+26.8%), $1.49 billion in FY2022 (+31.3%) and $1.13 billion in FY2021 (+8.4%).
- The Q2 2026 figure ranks as the highest quarterly Revenue in data going back to Q2 2010.
- Year over year, Revenue has now increased in each of the last 20 quarters, with growth averaging 26.5% over the last eight quarters.
- Over the past five years, the year-over-year growth in Revenue ranged from 11.1% (Q1 2025) to 42.2% (Q1 2026).
- Per Business Quant data, the three quarters before Q2 2026 came in at $814.5 million (Q1 2026), $805.5 million (Q4 2025) and $794.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | 959.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 959.00 Mn |
| Mar 31, 2026 | 814.50 Mn |
| Dec 31, 2025 | 805.50 Mn |
| Sep 30, 2025 | 794.90 Mn |
| Jun 30, 2025 | 687.50 Mn |
| Mar 31, 2025 | 572.60 Mn |
| Dec 31, 2024 | 627.70 Mn |
| Sep 30, 2024 | 622.10 Mn |
| Jun 30, 2024 | 590.20 Mn |
| Mar 31, 2024 | 515.30 Mn |
| Dec 31, 2023 | 515.20 Mn |
| Sep 30, 2023 | 498.80 Mn |
| Jun 30, 2023 | 452.70 Mn |
| Mar 31, 2023 | 420.40 Mn |
| Dec 31, 2022 | 412.00 Mn |
| Sep 30, 2022 | 387.90 Mn |
| Jun 30, 2022 | 378.20 Mn |
| Mar 31, 2022 | 310.60 Mn |
| Dec 31, 2021 | 312.00 Mn |
| Sep 30, 2021 | 296.00 Mn |
API Access
Neurocrine Biosciences Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();